CRA Position Statement on Safety of Hydroxychloroquine

The Canadian Rheumatology Association (CRA) is aware of the increasing number of questions rheumatologists are receiving pertaining to hydroxychloroquine (HCQ) and cardiotoxicity. Today, we have released a position statement which provides clarification on the safety of HCQ in the treatment of rheumatic diseases.

See their position statement below: